A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson’s disease

by Andrea Bril, Santiago Perez-Lloret, Malco Rossi, Sofía Fariña, Pierre Morisset, Laura Sorrentino, Micaela Iglesias, Alex Medina Escobar, Patricio Millar Vernetti, Daniel Cerquetti, Marcelo Merello
Published 2017-05-01

Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases

by Yoshiki Takamatsu, Gilbert Ho, Wakako Koike, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Jianshe Wei, Kazunari Sekiyama, Makoto Hashimoto
Published 2017-01-01

Imaging Parkinson’s disease below the neck

by Per Borghammer, Karoline Knudsen, Tatyana D. Fedorova, David J. Brooks
Published 2017-04-01

Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series

by Meghan Humbert, James Findley, Maria Hernandez-Con, Lana M. Chahine
Published 2017-07-01

Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease

by Reinhard Stöger, Paula J. Scaife, Freya Shephard, Lisa Chakrabarti
Published 2017-02-01

Synaptic proteins in CSF relate to Parkinson’s disease stage markers

by Erika Bereczki, Anna Bogstedt, Kina Höglund, Panagiota Tsitsi, Lovisa Brodin, Clive Ballard, Per Svenningsson, Dag Aarsland
Published 2017-02-01

Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses

by Franziska Albrecht, Sandrine Bisenius, Rodrigo Morales Schaack, Jane Neumann, Matthias L. Schroeter
Published 2017-03-01

Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity

by Laurie K. Mischley, Richard C. Lau, Noel S. Weiss
Published 2017-06-01

Insomnia and somnolence in idiopathic RBD: a prospective cohort study

by Ronald B. Postuma, Jean-François Gagnon, Amelie Pelletier, Jacques Y. Montplaisir
Published 2017-03-01

Response inhibition in Parkinson’s disease: a meta-analysis of dopaminergic medication and disease duration effects

by Peter Manza, Matthew Amandola, Vivekanand Tatineni, Chiang-shan R. Li, Hoi-Chung Leung
Published 2017-07-01

Integrated molecular landscape of Parkinson’s disease

by C. J. H. M. Klemann, G. J. M. Martens, M. Sharma, M. B. Martens, O. Isacson, T. Gasser, J. E. Visser, G. Poelmans
Published 2017-04-01

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?

by MA Qamar, A Sauerbier, M Politis, H Carr, P Loehrer, K Ray Chaudhuri
Published 2017-01-01

Embryonic development of selectively vulnerable neurons in Parkinson’s disease

by Miguel A. P. Oliveira, Rudi Balling, Marten P. Smidt, Ronan M. T. Fleming
Published 2017-06-01

Imaging tau pathology in Parkinsonisms

by Sarah Coakeley, Antonio P. Strafella
Published 2017-06-01

Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale

by Pablo Martinez-Martin, Jose Manuel Rojo-Abuin, Alexandra Rizos, Carmen Rodriguez-Blazquez, Claudia Trenkwalder, Lauren Perkins, Anna Sauerbier, Per Odin, Angelo Antonini, Kallol Ray Chaudhuri, on behalf of KPPS, EUROPAR and the IPMDS Non Motor PD Study Group
Published 2017-03-01

Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi...

by Shankar Sadasivan, Bridgett Sharp, Stacey Schultz-Cherry, Richard Jay Smeyne
Published 2017-05-01

Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?

by Satoshi Sakaue, Takashi Kasai, Ikuko Mizuta, Masaya Suematsu, Shinya Osone, Yumiko Azuma, Toshihiko Imamura, Takahiko Tokuda, Hitoshi Kanno, Omar M. A. El-Agnaf, Masafumi Morimoto, Masanori Nakagawa, Hajime Hosoi, Toshiki Mizuno
Published 2017-03-01

Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm

by J. William Langston, Jesse C. Wiley, Michele Tagliati
Published 2018-02-01

Irritable bowel syndrome and Parkinson’s disease risk: register-based studies

by Bojing Liu, Arvid Sjölander, Nancy L. Pedersen, Jonas F. Ludvigsson, Honglei Chen, Fang Fang, Karin Wirdefeldt
Published 2021-01-01

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease

by Luigi Zecca, Christian Pifl, Stanley Fahn, David Sulzer, Ruggero G. Fariello
Published 2021-01-01